Neurocrine Biosciences’ Analyst Day and Webcast on Tuesday, December 5, 2023
Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, will hold its Analyst Day focused on its R&D portfolio and strategy on Tuesday, December 5, 2023 in New York. The event will be held in-person and via webcast. It will feature Kevin Gorman, Chief Executive Officer, and Jude Onyia, Chief Scientific Officer, as well as additional members of Neurocrine Biosciences’ management team who will facilitate a panel discussion on the burden of congenital adrenal hyperplasia.
The event schedule and Zoom webcast information is as follows:
- Analyst Day Event: 1:00 p.m. – 3:45 p.m. Eastern Time
- Zoom Webinar ID: 831 1056 0450
- Zoom Passcode: 536894
Placeholder Link to Corporate Presentation [to be Updated Following Event Conclusion]
Neurocrine Biosciences to Present at the Jefferies London Healthcare Conference
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Jefferies London Healthcare Conference on Tuesday November 14, 2023 at 3:00 p.m. Greenwich Mean Time (10:00 a.m. Eastern Time) in London. Kevin Gorman, Chief Executive Officer, and additional members of Neurocrine management will present at the conference.